Biotech Giant Amgen Tops Views, Though Blockbuster Sales Dip [Investor's Business Daily]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Investors Business Daily
Related news Amgen ( AMGN ) topped third-quarter expectations late Tuesday with sales from cholesterol-busting drug Repatha leading the way, though the biotech giant's biggest drug slipped 5%. In after-hours trading on the stock market today , Amgen stock dipped a fraction after closing up 0.5%, at 189.08. Amgen stock has lost nearly 9% this month amid a broader sell-off for biotech companies . Still, shares remain up that much year to date. For the third quarter, Amgen reported adjusted earnings of $3.69 per share, rising 13% to top the estimates of analysts polled by Zacks Investment Research for $3.42. Total sales of $5.9 billion advanced 2% and beat views for $5.82 billion. The biotech giant credited its better-than-expected adjusted earnings growth to "higher total revenues, a lower tax rate and lower weighted-average shares outstanding." Chief Executive Robert Bradway noted new products drove sales growth in the quarter. "We are in the early stages of launching several new prod
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at UBS Group AG from $314.00 to $284.00. They now have a "neutral" rating on the stock.MarketBeat
- Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at TD Cowen from $370.00 to $360.00. They now have a "buy" rating on the stock.MarketBeat
- Can This High-Yield Dividend Stock Keep Beating the S&P 500? [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 2/6/24 - Beat
AMGN
Sec Filings
- 4/17/24 - Form DEFA14A
- 4/17/24 - Form DEF
- 4/10/24 - Form ARS
- AMGN's page on the SEC website